Lavrentaki Aikaterini

Title: Consultant in Endocrinology Diabetes and Metabolism | Metropolitan Hospital (March 2023- present)

Education:

MSc, "Research in Female Reproduction" | October 2019. National and Kapodistrian University of Athens, School of Medicine.
Thesis: "Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus". Supervisor: A. A. Tahrani

Master of Arts (M.A.) in Bioethics | November 2016. Joint Graduate Programme in Bioethics. University of Crete, Department of Philosophy and Social Studies, Rethymno, Crete, Greece.
Thesis: "Risks of ovarian stimulation during IVF on maternal health- bioethical issues". Advisor: Professor I. Athanassakis

MD | April 2009. University of Crete, School of Medicine

Expertise:

Dr. Lavrentaki completed her training at the Department of Endocrinology, Diabetes, and Metabolism at Evangelismos Hospital. The department is a designated center of expertise for rare endocrine diseases of the pituitary and adrenal glands, thyroid cancer, and multidisciplinary care for diabetes mellitus.

* Scientific associate, Endocrinology Unit, Center of Excellence in Neuroendocrine Tumors of the National and Kapodistrian University of Athens, First Department of Propaedeutic and Internal Medicine (APPK) of the University General Hospital of Athens (GHA) "Laiko". (June 2024- present)
* Registrar, Endocrinologist - Diabetologist, Metropolitan Hospital (March 2023-present)
* Consultant, Bioclinic Athens- Bioiatriki Healthcare Group (Oct 2023- Sept 2025)
* Private Clinic, Athens & Heraklion- Crete, Greece (July 2023- present)
* Internship, Department of Endocrinology Diabetes and Metabolism, Evangelismos Hospital. Athens, Greece (July 2018 – 2022).
* Clinical attachment in Diabetes and Endocrinology Centre Heartlands Hospital, Part of University Hospitals Birmingham, NHS Foundation Trust, Birmingham, UK (Oct 2017- Feb 2018)
* Clinical attachment, The Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, NHS Oxford, UK (August 2014)
* Resident in Internal Medicine, Department of Internal Medicine, General Hospital of Rethimno, Crete, Greece. Extended contract for 6 months in Pulmonary clinic and 6 months in Hemodialysis Unit. (March 2012 - Sept 2014).
* Rural medical service, 3 months practice as Physician- General Practitioner in General Hospital of Chania, (Internal Medicine & Surgical department), followed by service in the Community Clinic of Gavdos Island, Peripheral Primary Care Centre of Kandanos Chania, Crete, Greece. (June 2010 - June 2011)

* Member of Hellenic Endocrine Society
* Member of ESE, The European Society of Endocrinology
* Member of Athens, Piraeus & Heraklion Medical Associations

Dr. Lavrentaki has participated in numerous studies published in reputable, peer-reviewed international journals. Additionally, she has contributed to international clinical trials evaluating the safety and efficacy of novel therapies for endocrine disorders, such as Acromegaly and Congenital Adrenal Hyperplasia.

Scientific Publications:

1. Book chapter "Endocrine Consequences Following Immune Checkpoint Inhibitors Therapy". Handbook of Cancer and immunology. edited by Nima Rezaei, Springer Nature. Submission due: May 15, 2022.
2. Aikaterini Lavrentaki, Tom Thomas, Anuradhaa Subramanian, George Valsamakis, Neil Thomas, Konstantinos A Toulis, Jingya Wang, Barbara Daly, Ponnusamy Saravanan, Dana Sumilo, George Mastorakos, Abd A Tahrani, Krishnarajah Nirantharakumar. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis. J Diabetes Complications. 2019 Oct; 33(10):107401.
3. Aikaterini Lavrentaki, Asad Ali, Brendan Cooper, Abd A Tahrani. Mechanisms of disease: The Endocrinology of obstructive sleep apnoea. Eur J Endocrinol. 2018 Dec 1. pii: EJE-18-0411.R1. doi: 10.1530/EJE-18-0411
4. Fountas A, Lavrentaki A, Subramanian A, Toulis KA, Nirantharakumar K, Karavitaki N. Recurrence in silent corticotroph adenomas after primary treatment: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2018 Dec 21. doi: 10.1210/jc.2018-01956
5. Pelekanou V, Anastasiou E, Bakogeorgou E, Notas G, Kampa M, Garcia-Milian R, Lavredaki K, Moustou E, Chinari G. Arapantoni P, O' Grady A, Georgoulias V, Tsapis A, Stathopoulos EN, Castanas E. Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in Non-Small Cell Lung Carcinoma. Steroids. 2018 Feb 15. pii: S0039-128X(18)30016-3. doi: 10.1016/j.steroids.2018.01.008
6. Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017 Feb; 20(1):4-9. doi: 10.1007/s11102-016-0754-x. Review
7. Notas G, Bariotakis M, Kalogrias V, Andrianaki M, Azariadis K, Kampouri E, Theodoropoulou K, Lavrentaki K, Kastrinakis S, Kampa M, Agouridakis P, Pirintsos S, Castanas E. Accurate Prediction of Severe Allergic Reactions by a Small Set of Environmental Parameters (NDVI, Temperature). PLoS One. 2015 Apr 29;10(4):e0127604
8. Kampa M, Notas G, Pelekanou V, Troullinaki M, Andrianaki M, Azariadis K, Kampouri E, Lavrentaki K, Castanas E. Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx). Steroids. 2012 Aug;77(10):959-67.